AMIT MUNSHI
Profile
First Name
: AMIT
Middle Name
:
Last Name
: MUNSHI
Related Companies
Titles
Company Name
Related People
DIRECTOR
DAVID ANDERSON, PAUL ANDERSON, SARA BARRINGTON, PAUL BILLINGS, SCOTT BOGART, ANDREW BOTELER, GORDON ROY DAVIS, ROY DAVIS, ANDRE DE FUSCO, DAOTIAN FU, DAOTIAN FU, PH.D, ANDRE FUSCO, ANDRE DE FUSCO, ANDRE DE FUSCO, HARRY GELLES, FREDERICK GLUCK, ALAN HEEGER, JEFFREY KOB, JIANING LIU, JAMES MCCULLOUGH, PAUL MEYER, PAUL PAGANO, YUCAI PENG, PH.D, MICHAEL PFAU, MICHAEL E. PFAU, SIMON RAAB, TOM HYHONGSOK SOH, TOM HYONGSOK SOH, DENNIS STUBBLEFIELD, DENNIS STUFFBLEFIE, JUSTIN XIANG
DIRECTOR
DIRECTOR
AKIHISA AKAO, HOJABR ALIMI, RICHARD BATYCKY, TODD BAZEMORE, CHRISTOPHER CABELL, ROBERT CLARKE, RICHARD CONLEY, WILLIAM DUKE, GREGORY FRENCH, STEVEN GILLIS, KURT GRAVES, SAMEER HARISH, DAVID HAVA, MICHAEL HIGGINS, MICHAEL J. HIGGINS, MARK IWICKI, PETER LUDLUM, DAVID MAKI, TERRANCE MCGUIRE, AMIT D. MUNSHI, . OCULUS INNOVATIVE SCIENCES, INC., TEOFILO RAAD, JAMES ROACH, SCOTT ROCKLAGE, MATTHEW SHERMAN, MICHELLE S. SIEGERT, ANAND VARADAN
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2025-11-12
D
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
DECLINE TO DISCLOSE
Equity
2024-04-22
D
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
NO REVENUES
Equity
2023-05-01
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2020-09-25
